BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8391003)

  • 1. Novel action of transforming growth factor beta 1 in functioning human pancreatic carcinoid cells.
    Ishizuka J; Beauchamp RD; Sato K; Townsend CM; Thompson JC
    J Cell Physiol; 1993 Jul; 156(1):112-8. PubMed ID: 8391003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-mediated autocrine growth-stimulatory effect of 5-hydroxytryptamine on cultured human pancreatic carcinoid cells.
    Ishizuka J; Beauchamp RD; Townsend CM; Greeley GH; Thompson JC
    J Cell Physiol; 1992 Jan; 150(1):1-7. PubMed ID: 1309821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
    Rowland-Goldsmith MA; Maruyama H; Kusama T; Ralli S; Korc M
    Clin Cancer Res; 2001 Sep; 7(9):2931-40. PubMed ID: 11555612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth.
    Ohmura E; Okada M; Onoda N; Kamiya Y; Murakami H; Tsushima T; Shizume K
    Cancer Res; 1990 Jan; 50(1):103-7. PubMed ID: 2152769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different signals mediate transforming growth factor-beta 1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells.
    Franzén P; Ichijo H; Miyazono K
    Exp Cell Res; 1993 Jul; 207(1):1-7. PubMed ID: 7686495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human carcinoid cell production of paracrine growth factors that can stimulate fibroblast and endothelial cell growth.
    Beauchamp RD; Coffey RJ; Lyons RM; Perkett EA; Townsend CM; Moses HL
    Cancer Res; 1991 Oct; 51(19):5253-60. PubMed ID: 1913648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate.
    Sing GK; Ruscetti FW; Beckwith M; Keller JR; Ellingsworth L; Urba WJ; Longo DL
    Cell Growth Differ; 1990 Nov; 1(11):549-57. PubMed ID: 1965139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
    Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
    Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
    Hébert CD; Birnbaum LS
    Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of transforming growth factor beta on human neuroendocrine tumor BON cell proliferation and differentiation is mediated through somatostatin signaling.
    Leu FP; Nandi M; Niu C
    Mol Cancer Res; 2008 Jun; 6(6):1029-42. PubMed ID: 18567806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gastrin on 3',5'-cyclic adenosine monophosphate, intracellular calcium, and phosphatidylinositol hydrolysis in human colon cancer cells.
    Ishizuka J; Townsend CM; Bold RJ; Martinez J; Rodriguez M; Thompson JC
    Cancer Res; 1994 Apr; 54(8):2129-35. PubMed ID: 8174118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies of the role of transforming growth factor-beta in human B cell function.
    Kehrl JH; Taylor AS; Delsing GA; Roberts AB; Sporn MB; Fauci AS
    J Immunol; 1989 Sep; 143(6):1868-74. PubMed ID: 2550546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
    Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
    Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytes.
    Vaday GG; Schor H; Rahat MA; Lahat N; Lider O
    J Leukoc Biol; 2001 Apr; 69(4):613-21. PubMed ID: 11310848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased transforming growth factor-beta response and binding in insulin-independent teratoma-derived cell lines with increased tumorigenic properties.
    Serrero G; Zhou J; Mills D; LePak N
    J Cell Physiol; 1991 Dec; 149(3):503-11. PubMed ID: 1660484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
    Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
    Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta 1 supports autonomous growth of human papillomavirus-immortalized cervical keratinocytes under conditions promoting squamous differentiation.
    Woodworth CD; Chung J; McMullin E; Plowman GD; Simpson S; Iglesias M
    Cell Growth Differ; 1996 Jun; 7(6):811-20. PubMed ID: 8780894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta enhances calcitonin-induced cyclic AMP production and the number of calcitonin receptors in long-term cultures of human umbilical cord blood monocytes in the presence of 1,25-dihydroxycholecalciferol.
    Mbalaviele G; Orcel P; Bouizar Z; Jullienne A; De Vernejoul MC
    J Cell Physiol; 1992 Sep; 152(3):486-93. PubMed ID: 1324244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y; Kyprianou N
    Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.